Resmed (RMD) Inventory (2010 - 2026)

Resmed's Inventory history runs 17 years deep, the most recent figure standing at $911.9 million for Q1 2026.

• Quarterly Inventory rose 5.71% year-over-year to $911.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $911.9 million (up 5.71% YoY) and the FY2025 annual result came in at $927.7 million, up 12.83% from the prior year.
• Inventory was $911.9 million for Q1 2026 at Resmed, down from $922.0 million in the prior quarter.
• Across five years, Inventory topped out at $1.0 billion in Q1 2023 and bottomed at $664.9 million in Q1 2022.
• A 5-year average of $893.3 million and a median of $918.0 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory surged 70.7% — and 2024, when it dropped 17.98%.
• Resmed's Inventory stood at $989.0 million in 2022, then declined by 5.64% to $933.2 million in 2023, then declined by 5.48% to $882.1 million in 2024, then grew by 4.53% to $922.0 million in 2025, then fell by 1.1% to $911.9 million in 2026.
• Business Quant data shows RMD's Inventory at $911.9 million in Q1 2026, $922.0 million in Q4 2025, and $945.8 million in Q3 2025.